Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Terry Smith, latest 13F

Catalyst Pharmaceuticals

In Terry Smith's portfolio · Fundsmith

Ticker CPRX

Not in the portfolio as of Q2 2026. Every quarter it shows up in a Fundsmith 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q2 2026 Sell 0  
Q1 2026 Reduce 75% 844,887 0.1% $24.76 $20.9M
Q4 2025 No change 3,363,807 0.3% $23.34 $78.5M
Q3 2025 Add 24% 3,363,807 0.3% $19.70 $66.3M
Q2 2025 Add 26% 2,709,086 0.2% $21.70 $58.8M
Q1 2025 Buy 2,151,274 0.2% $24.25 $52.2M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.